New Feature Coming Soon, Stay Tuned!
Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
LSE
Unprofitable
EPS improving
Unprofitable
EPS improving
-0.00Â ( -0.93%)
After-hours NaN$
0.00 (0.00%)
Relative Strenght
Volume Buzz
-67%
Earning Acce
Yes
Dist 52w H.
53%